Fitness Daily /> Posts About DMCA Privacy Contact
Possible Side Effects of CAPLYTA® (lumateperone)

caplyta side effects - Fitness Daily

Lumateperone ... Lumateperone, sold under the brand name Caplyta, is an atypical antipsychotic medication of the pyridopyrroloquinoxaline and butyrophenone families. CAPLYTA may cause fertility probl...

Lumateperone ... Lumateperone, sold under the brand name Caplyta, is an atypical antipsychotic medication of the pyridopyrroloquinoxaline and butyrophenone families. CAPLYTA may cause fertility problems in females and males.

Understanding the Context

You should notify your healthcare provider if you become pregnant or intend to become pregnant while taking CAPLYTA. There … · Caplyta is used to treat adults with schizophrenia, depression associated with bipolar I or bipolar II disorder (manic depression), or along with antidepressant medicines to … · Caplyta is an oral capsule that is used to treat mental health conditions, including schizophrenia, depression, and bipolar disorder. Common side effects include dizziness, … · Caplyta (lumateperone) is a prescription capsule that’s used to treat schizophrenia and bipolar depression. Learn about side effects, uses, dosage, and more.

Possible Side Effects of CAPLYTA® (lumateperone)

Key Insights

· Caplyta (Lumateperone Capsules) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug … · These highlights do not include all the information needed to use CAPLYTA safely and effectively. See full prescribing information for CAPLYTA. CAPLYTA® (lumateperone) … · Learn about cost, uses, and more for Caplyta (lumateperone), which is a prescription capsule that treats schizophrenia and bipolar disorder in adults. Lumateperone (Caplyta) DOWNLOAD PDF Generic name: lumateperone (loo-mah-te-per-one) Brand name: Caplyta™ Capsule: 42 mg, 21 mg, 10.5 mg All FDA warnings are at the end of … The rates of syncope for CAPLYTA and placebo were 0.3% and 0.5%, respectively in the monotherapy trials, and there were no reports for CAPLYTA or placebo in the adjunctive …